News from NORD

New Guidelines Published for Diagnosis and Management of Cystathionine Beta-Synthase Deficiency

Publish date: December 5, 2016

 

New guidelines for the diagnosis and management of cystathionine beta-synthase deficiency have been published in the Journal of Inherited Metabolic Disease . The HCU Network Australia recently hosted an online webinar featuring Andrew Morris MD, the primary author of the new guidelines.

Recommended Reading

European Commission’s proposed criteria for endocrine disruptors trigger multiple concerns
MDedge Endocrinology
NORD Urges Congress to Pass 21st Century Cures Act
MDedge Endocrinology
Nominate a Colleague for a NORD 2017 Rare Impact Award
MDedge Endocrinology
NORD Encourages Observing Rare Disease Day in Hospitals and Academic Centers
MDedge Endocrinology
January 13 Is Deadline for NORD Rare Impact Award Nominations
MDedge Endocrinology
Running Marathons to Advance Rare Disease Awareness and Diagnosis
MDedge Endocrinology
Major Three-Year Study of Undiagnosed Diseases Announced
MDedge Endocrinology
Presentation Chronicles Pathway to Erdheim-Chester Diagnosis
MDedge Endocrinology
Patients Are Being Recruited for LPL-Deficiency Study
MDedge Endocrinology
Speaking of NEC Podcast Series Now Has Companion Brochure
MDedge Endocrinology